Certified by Founder Lodge
Advent Life Sciences
United Kingdom - London
INVESTOR
1 Disclosed Funding Rounds $40,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced
Company | Date | Round | Raised |
---|---|---|---|
Moximed | August, 16 ,2022 | Series C | $40,000,000 |
Proximie | August, 14 ,2022 | Series C | $80,000,000 |
Nalu Medical, Inc. | January, 05 ,2024 | Unknown | $65,000,000 |
Curve Therapeutics | February, 28 ,2024 | Series A | $51,183,495 |